TREA

90160128 - EUGAMM

Follow

Information

  • Trademark
  • 90160128
  • Serial Number
    90160128
  • Filing Date
    September 04, 2020
    4 years ago
  • Transaction Date
    July 22, 2024
    5 months ago
  • Status Date
    July 22, 2024
    5 months ago
  • Published for Opposition Date
    April 20, 2021
    3 years ago
  • Location Date
    November 13, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    HOWELL, MATTHEW PATTER
  • Attorney Docket Number
    5734-0285TM
    Attorney Name
    Yoon S. Ham
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EUGAMM
Case File Statements
  • GS0051: Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin preparations, namely, pharmaceutical immunoglobulin preparations for diagnosis of primary humoral immunodeficiency, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome, severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), for preventing primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), and for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP)
Case File Event Statements
  • 9/8/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/9/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/12/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/13/2021 - 3 years ago
    4 - PRIORITY ACTION WRITTEN Type: CPRA
  • 1/13/2021 - 3 years ago
    5 - PRIORITY ACTION E-MAILED Type: GPRA
  • 1/13/2021 - 3 years ago
    6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 3/10/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/11/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/10/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/12/2021 - 3 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/31/2021 - 3 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/20/2021 - 3 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/20/2021 - 3 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/4/2022 - 2 years ago
    21 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/15/2021 - 3 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/24/2021 - 3 years ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/24/2021 - 3 years ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 11/24/2021 - 3 years ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/26/2021 - 3 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/4/2022 - 2 years ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/4/2022 - 2 years ago
    20 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/15/2022 - 2 years ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/6/2022 - 2 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/13/2023 - a year ago
    32 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/15/2022 - 2 years ago
    24 - SOU EXTENSION 3 FILED Type: EXT3
  • 11/15/2022 - 2 years ago
    25 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 11/17/2022 - 2 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/17/2023 - a year ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/17/2023 - a year ago
    28 - SOU EXTENSION 4 FILED Type: EXT4
  • 5/17/2023 - a year ago
    29 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 5/19/2023 - a year ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/6/2023 - a year ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/6/2023 - a year ago
    33 - SOU EXTENSION 5 FILED Type: EXT5
  • 7/22/2024 - 5 months ago
    36 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/22/2024 - 5 months ago
    37 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 11/13/2023 - a year ago
    34 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 11/14/2023 - a year ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA